These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29657375)

  • 1. Comparison of Glycemic Control between Continuous Regular Insulin Infusion and Single-dose Subcutaneous Insulin Glargine Injection in Medical Critically Ill Patients.
    Bhurayanontachai R; Rattanaprapat T; Kongkamol C
    Indian J Crit Care Med; 2018 Mar; 22(3):174-179. PubMed ID: 29657375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.
    Schmeltz LR; DeSantis AJ; Schmidt K; O'Shea-Mahler E; Rhee C; Brandt S; Peterson S; Molitch ME
    Endocr Pract; 2006; 12(6):641-50. PubMed ID: 17229660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
    Yeldandi RR; Lurie A; Baldwin D
    Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study.
    Nader ND; Hamishehkar H; Naghizadeh A; Shadvar K; Iranpour A; Sanaie S; Chang F; Mahmoodpoor A
    Diabetes Metab Syndr Obes; 2020; 13():671-678. PubMed ID: 32210600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.
    Truong S; Park A; Kamalay S; Hung N; Meyer JG; Nguyen N; Momenzadeh A
    Nutr Clin Pract; 2019 Oct; 34(5):775-782. PubMed ID: 30693980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing.
    Fox MA; Perry MC; Liu-DeRyke X
    Pharmacotherapy; 2020 Mar; 40(3):186-190. PubMed ID: 31995840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
    Hakeam HA; Mulia HA; Azzam A; Amin T
    JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial.
    Silinskie KM; Kirshner R; Hite MS
    Ann Pharmacother; 2013 Jan; 47(1):20-8. PubMed ID: 23324510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of blood glucose during enteral nutrition in critical patients].
    Liu Y; He W; Zhou H; Li T; Xu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Sep; 24(9):546-9. PubMed ID: 22938664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial.
    Datta S; Qaadir A; Villanueva G; Baldwin D
    Endocr Pract; 2007; 13(3):225-31. PubMed ID: 17599852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial.
    Oghazian MB; Javadi MR; Radfar M; Torkamandi H; Sadeghi M; Hayatshahi A; Gholami K
    Pharmacotherapy; 2015 Feb; 35(2):148-57. PubMed ID: 25689245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal-prandial insulin delivery in type 2 diabetes mellitus via the V-Go: a novel continuous subcutaneous infusion device.
    Kapitza C; Fein S; Heinemann L; Schleusener D; Levesque S; Strange P
    J Diabetes Sci Technol; 2008 Jan; 2(1):40-6. PubMed ID: 19885176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study.
    Derakhshan P; Khatibi A; Faiz SHR; Rahimzadeh P; Nouri N
    Med J Islam Repub Iran; 2021; 35():31. PubMed ID: 34211933
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
    Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
    Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial.
    Olveira G; Abuín J; López R; Herranz S; García-Almeida JM; García-Malpartida K; Ferrer M; Cancer E; Luengo-Pérez LM; Álvarez J; Aragón C; Ocón MJ; García-Manzanares Á; Bretón I; Serrano-Aguayo P; Pérez-Ferre N; López-Gómez JJ; Olivares J; Arraiza C; Tejera C; Martín JD; García S; Abad ÁL; Alhambra MR; Zugasti A; Parra J; Torrejón S; Tapia MJ
    Clin Nutr; 2020 Feb; 39(2):388-394. PubMed ID: 30930133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control with use of insulin glargine after cardiothoracic surgery: a retrospective study.
    Ergin AB; Nasr G; Yared JP; Bena J; Nasr C
    Endocr Pract; 2013; 19(3):485-93. PubMed ID: 23425653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.